Drug Profile
CY 1787
Alternative Names: CY-1787; CY-1788Latest Information Update: 26 Apr 1999
Price :
$50
*
At a glance
- Originator Epimmune
- Developer Epimmune; Pharmacia Corporation; Sumitomo Pharmaceuticals
- Class Monoclonal antibodies
- Mechanism of Action E-selectin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Allergic rhinitis; Septic shock; Systemic inflammatory response syndrome
Most Recent Events
- 26 Apr 1999 Discontinued-I for Allergic rhinitis in United Kingdom (Unknown route)
- 26 Apr 1999 Discontinued-I for Septic shock in Belgium (Unknown route)
- 26 Apr 1999 Discontinued-Preclinical for Septic shock in Japan (Unknown route)